← All candidates
No insider filings on record.
12 filings on record.
HBIOHARVARD BIOSCIENCE INC
NasdaqCM · Healthcare · $27.69M
$8.00
-1.11% · Sep 15
No insider filings on record.
HARVARD BIOSCIENCE INC hasn't reported Form 4 activity yet.
Price · 1Y · dailyNo open-market activity in range
▸ hover a marker for the filing · drag to zoom · 4 moves explained
AI brief · from the filings on this pagePro
The filings, the score and the setup on this page, read for you in about ten seconds — what the insiders did, and what stands against it.
Market cap
$27.69M
Float
3.5M
78% public
Short % float
Pro
Price / profit
—
not yet profitable
Price / future profit
14.0
Price / sales
0.3
The record
newest first
No insider transactions on file for HBIO yet.
Context
Coverage
Harvard Bioscience Inc (HBIO) Q1 2026 Earnings Call Highlights: Revenue Growth Driven by New ...GuruFocus.com · 05-12Harvard Bioscience, Inc. Q1 2026 Earnings Call SummaryMoby · 05-12How The Harvard Bioscience (HBIO) Investment Narrative Is Resetting After Lower 2026 ExpectationsSimply Wall St. · 03-16Harvard Bioscience Inc (HBIO) Q4 2025 Earnings Call Highlights: Strong Operational Efficiency ...GuruFocus.com · 03-12
The file stays open
12 filings on record.
The next one will be too.
▸ SEC EDGAR · FINRA · Nasdaq — public sources only · research, not advice